Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

Blood

Volumn 88, Issue 1, 1996, Pages 335-340

  Price, Thomas H ^a,b   Chatta, Gurkamal S ^a   Dale, David C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; MITOSIS; NEUTROPHIL; NEUTROPHILIA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030003411     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.335.bloodjournal881335     Document Type: Article

References (44)

1. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Weite K, Souza L: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414, 1988
2. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164, 1991
3. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, Robinson W, Glaspy JA, Emerson S, Gabrilove J, Vincent M, Boxer LA: A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496, 1993
4. Metcalf D: Control of granulocytes and macrophages: Molecular, cellular, and clinical aspects. Science 254:529, 1991
5. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (two parts). N Engl J Med 327:28, 99, 1992
6. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 78:2791, 1991
7. Gabrilove J: The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 80:1382, 1992
8. Hammond WP, Csiba E, Canin A, Hockman H, Souza LM, Layton JE, Dale DC: Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 87:704, 1991
9. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737, 1994
10. Berk SL, Smith JK: Infectious diseases in the elderly. Med Clin North Am 67:273, 1983
11. Finkelstein MS, Petkun WM, Freedman ML, Antopol SC: Pneumococcal bacteremia in adults: Age-dependent differences in presentation and in outcome. J Am Geriatr Soc 31:19, 1983
12. Stead WW, Lofgren JP, Warren E, Thomas C: Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 312:1483, 1985
13. Baldwin JG: Hematopoietic function in the elderly. Arch Intern Med 148:2544, 1988
14. Chatta GS, Andrews RG, Rodger E, Schrag M, Hammond WP, Dale DC: Hematopoietic progenitors and aging: Alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 48:M207, 1993
15. Begg CB, Carbone PP: Clinical trials and drug toxicity in the elderly. The experience of the Eastern cooperative oncology group. Cancer 52:1986, 1983
16. Chatta GS, Price TH, Allen RC, Dale DC: Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 84:2923, 1994
17. Price TH, Lee MY, Dale DC, Finch CA: Neutrophil kinetics in chronic neutropenia. Blood 54:581, 1979
18. Cronkite EP, Bond VP, Fliedner TM, Killman SA: The use of tritiated thymidine in the study of hematopoietic cell proliferation. Ciba Found Symp 13:70, 1960
19. 32P-diisopropyl fluorophosphate for neutrophil kinetic studies. Acta Haematol 67:175, 1982
20. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE, Wintrobe MM: Leukokinetic studies IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40:989, 1961
21. Price TH. Dale DC: Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method, donor corticosteroid treatment, and short-term storage. Blood 54:977, 1979
22. Wright DG, Meierovics AI, Foxley JM: Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67:1023, 1986
23. Kerrigan DP, Castillo A, Foucar K, Townsend K, Neidhart J: Peripheral blood morphologic changes after high-dose antineoplastic chemotherapy and recombinant human granulocyte colony-stimulating factor administration. Am J Clin Path 92:280, 1989
24. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA: Neutrophil kinetics in man. J Clin Invest 58:705, 1976
25. Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962, 1990
26. Morstyn G, Nicola NA, Metcalf D: Separate actions of different colony stimulating factors from human placental conditioned medium on human hemopoietic progenitor cell survival and proliferation. J Cell Physiol 109:133, 1981
27. Begley CG, Nicola NA, Metcalf D: Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF. Blood 71:640, 1988
28. Morstyn G, Souza LM, Keech J, Sheridan W, Campbell L, Alton NK, Green M, Metcalf D, Fox R: Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:667, 1988
29. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM: Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56:809, 1987
30. Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, Dexter TM: The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 86:9499, 1989
31. Uchida T, Yamagiwa A: Kinetics of rG-CSF-induced neutrophilia in mice. Exp Hematol 20:152, 1992
32. Peters WP, Kurtzberg J, Atwater S, Borowitz M, Gilbert C, Rao M, Currie M, Shogan J, Jones RB, Shpall EJ, Souza L: Comparative effects of rHuG-CSF and rHuGM-CSF on hematopoietic reconstitution and granulocyte function following high dose chemotherapy and autologous bone marrow transplantation (ABMT). Blood 72:130a, 1988 (abstr, suppl 1)
33. Hammond WP, Price TH, Souza LM, Dale DC: Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320:1306, 1989
34. Chatta GS, Price TH, Stratton JR, Dale DC: Aging and marrow neutrophil reserves. J Am Geriatr Soc 42:77, 1994
35. Dale DC, Fauci AS, Guerry D, Wolff SM: Comparison of agents producing a neutrophilic leukocytosis in man. J Clin Invest 56:808, 1975
36. Peters WP, Stuart A, Affronti ML, Kim CS, Coleman RE: Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood 72:1310, 1988
37. Addison IE, Johnson B, Devereux S, Goldstone AH, Linch DC: Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo. Clin Exp Immunol 76:149, 1989
38. Liles WC, Rodger ER, Dale DC: Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18 and L-selectin following the administration of G-CSF in vivo and in vitro. Clin Res 42:304A, 1994 (abstr)
39. Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T: Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 84:574, 1993
40. Dale DC: Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis 18:S180, 1994 (suppl 2)
41. Silver GM, Gamelli RL, O'Reilly M: The beneficial effect of granulocyte colony-stimulating factor (G-CSF) on survival after Pseudomonas burn wound infection. Surgery 106:452, 1989
42. O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC: Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 33:679, 1992
43. Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffman WD, Banks SM, MacVittie TJ: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366, 1994
44. Chang JM, Metcalf D, Gonda TJ, Johnson GR: Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J Clin Invest 84:1488, 1989